Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ann Hanham currently holds 23,000 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ann Hanham has been a net seller of HTGM stock. They have purchased $15.4K and sold $5.4M worth of shares.
Ann Hanham's most recent insider trade was on Jun 20, 2024, when they sold 23,000 shares at $0.00 per share.
Ann Hanham serves as Executive at HTG MOLECULAR DIAGNOSTICS, INC (HTGM). They have executed 50 insider transactions totaling $5.4M over their tenure at the company.
Ann Hanham holds the position of Executive at HTG MOLECULAR DIAGNOSTICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ann Hanham has shown a selling trading pattern, with $15.4K in total purchases and $5.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ann Hanham was on Feb 4, 2011, when they purchased $2.8M worth of ECYT shares. This transaction involved 461,608 shares at $6.00 per share.
Ann Hanham currently owns 23,000 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ann Hanham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ann Hanham has 50 Form 4 filings on record as an insider at HTG MOLECULAR DIAGNOSTICS, INC.
Set alerts for Ann Hanham and 40,000+ other insiders.